KOD Kodiak Sciences Inc
$32.89▲ +0.06%
Healthcare
Other
After hours
$33.54▲ +1.98%
Sep 11, 7:30 PM ET
Volume 682.0K
Avg Volume (10D) 611.1K
Key Metrics & Fundamentals
Market Cap
$2.07B
P/E Ratio
–
Div Yield
–%
52W Range
9.10 - 47.84
% vs 50 MA
-17.73%
% vs 200 MA
-1.56%
RSI-14
29.4
MACD Histogram
-0.5800
Beta (1Y vs SPY)
1.20
Free Cash Flow
-$46.59M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$60.65M
COGS
–
Operating Exp
$66.84M
Operating Income
-$66.84M
EBIT
-$66.84M
Pretax Income
-$65.64M
Net Income
-$65.64M
EPS (Diluted)
-1.05
Price & Volume History
Loading chart…
Recent News
Kodiak Sciences (KOD) Races Toward Three Make-Or-Break Trial Verdicts
Insider Monkey · Sep 3, 2026 10:58 AM
Kodiak's Q2 Loss Wider Than Expected, Pipeline Development in Focus
Zacks · Aug 14, 2026 2:14 PM
Kodiak Sciences Announces Recent Business Highlights and Second Quarter 2026 Financial Results
PR Newswire · Aug 13, 2026 8:00 PM
KOD Begins Late-Stage Study of KSI-501 in Diabetic Macular Edema
Zacks · Aug 11, 2026 3:15 PM
Kodiak Sciences Says First Patients Enrolled in Late-Stage Diabetic Eye Disease Trial
MT Newswires · Aug 10, 2026 9:49 PM
Kodiak Sciences Announces First Patients Enrolled in Global Phase 3 ALTO trial of KSI-501 in Patients with Diabetic Macular Edema
PR Newswire · Aug 10, 2026 8:35 PM
Kodiak Sciences Completes Enrollment in First Pivotal Cohort in the Phase 3 PEAK Trial of KSI-101 for Macular Edema Secondary to Inflammation and Reaffirms Topline Clinical Data Release Remains on Track for December 2026
PR Newswire · Aug 6, 2026 11:00 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See KOD's money flow as a full page
Social Sentiment
Avg +0.80 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.